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The bacterial ribosome is a major antibiotic target
1. Despite
the large size of the ribosome, and the chemical diversity of
ribosome-targeting small compounds, only a few sites on
the ribosome are known to be bound by clinically used anti-
biotics. On the 50S large ribosomal subunit, two of the major
antibiotic-binding sites are the peptidyl transferase centre (PTC)
and the nascent peptide exit tunnel. The PTC is targeted by
pleuromutilin, lincosamide and streptogramin A (PLSA) anti-
biotics, as well as phenicols and oxazolidinones2–6. Representa-
tives of macrolide and streptogramin B classes bind at adjacent
sites at the beginning of the nascent peptide exit tunnel3,5. In
contrast to the macrolides and streptogramin B antibiotics that
predominantly inhibit translation during elongation7, the PLSA
antibiotics overlap with the amino acids attached to the CCA-
ends of the A- and/or P-site of tRNAs and trap ribosomes during
or directly after initiation8–10. This is highlighted by the recent
usage of the pleuromutilin retapamulin to identify translation
initiation sites in Ribo-Seq experiments8.
Many mechanisms have evolved to overcome growth inhibi-
tion by such antibiotics in bacteria, among them target protection
mediated by a subset of ABC family of proteins11. ATP-binding
cassette (ABC) ATPases are a ubiquitous superfamily of proteins
found in all domains of life, best-known as components of
membrane transporters12,13. A typical ABC transporter contains
two nucleotide-binding domains (NBDs), each of which con-
tribute one of two faces to an ATP-binding pocket, as well as
transmembrane domains14. Some sub-groups of ABC proteins,
however, lack membrane-spanning regions and have alternative
cytoplasmic functions, such as being involved in translation15–17.
For example, in eukaryotes Rli1/ABCE1 is a ribosome splitting
factor involved in recycling after translation termination, and the
fungal eEF3 proteins bind the ribosome to facilitate late steps of
translocation and E-site tRNA release18,19. The F-type subfamily
of ABC proteins, which are present in bacteria and eukaryotes,
contain at least two NBDs separated by an α-helical interdomain
linker and notably lack transmembrane regions20–22.
One group of bacterial ABCFs, which are termed antibiotic
resistance (ARE) ABCFs23, confer resistance to antibiotics that
bind to the 50S subunit of the bacterial ribosome11,21,24,25.
Characterized ARE-ABCFs are found predominantly in Gram-
positive bacteria, including human and animal pathogens, typi-
cally have a restricted host specificity, and can be further divided
into eight subfamilies11,20,26. Although initially thought to act as
part of efflux systems27,28, these proteins were subsequently
shown instead to bind the ribosome, oppose antibiotic binding,
and to reverse antibiotic-mediated inhibition of translation
in vitro29.
Phylogenetic analyses indicate that ARE-ABCFs may have
arisen multiple times through convergent evolution, and that
antibiotic specificity can be divergent within a related subgroup20.
Classified by the spectrum of conferred antibiotic resistance,
ARE-ABCFs can be categorized into eight subfamilies with three
different resistance spectra20,25:
1. A highly polyphyletic group of ARE-ABCFs that confer
resistance to the PTC-binding PLSA antibiotics (ARE1,
ARE2, ARE3, ARE5 and ARE6 subfamilies). The most well-
studied representatives are VmlR, VgaA, SalA, LmrC and
LsaA26,30–33. Additionally, a lincomycin-resistance ABCF
that belongs to this group, termed Lmo0919, has been
reported in Listeria monocytogenes34–36.
2. ARE-ABCFs that confer resistance to antibiotics that bind
within the nascent peptide exit channel (a subset of the
ARE1 subfamily, and ARE4). The most well-studied
representatives are Macrolide and streptogramin B resis-
tance (Msr) proteins28,37,38.
3. Poorly experimentally characterized ARE-ABCF proteins
belonging to subfamilies ARE7 (such as OptrA) and ARE8
(PoxtA). These resistance factors confer resistance to
phenicols and oxazolidinones that bind in the PTC
overlapping with the PLSA-binding site11,39,40 and are
spreading rapidly throughout bacteria in humans and
livestock by horizontal gene transfer41–44.
Additionally, several largely unexplored groups of predicted
novel ARE-ABCFs are found in high-GC Gram-positive bacteria
associated with antibiotic production20.
So far, two structures of ARE-ABCFs bound to the 70S ribo-
some have been determined24,38,45. In each instance, the ARE-
ABCF interdomain linker extends from the E-site-bound NBDs
into the relevant antibiotic-binding site in the ribosome, dis-
torting the P-site tRNA into a non-canonical state located
between the P and E sites. The tip of the interdomain linker—
termed the antibiotic resistance determinant (ARD) in ARE-
ABCFs—is not well conserved among (and sometimes not even
within) subfamilies, and mutations in this region can abolish
activity as well as change antibiotic specificity. Mutagenesis
indicates that both steric overlap between the ARD and the
antibiotic, as well as indirect reconfiguration of the rRNA and the
antibiotic-binding site, may contribute to antibiotic
resistance24,38,45,46. Non-ARE ribosome-associated ABCFs that
do not confer resistance to antibiotics—such as EttA—tend to
have relatively short interdomain linkers that contact and stabi-
lize the P-site tRNA22,47. ARE-ABCFs that confer resistance to
PLSA antibiotics (such as VmlR) have extensions in the inter-
domain linker that allow them to reach into the antibiotic-
binding site in the PTC45. The longest interdomain linkers belong
to ARE-ABCFs that confer resistance to macrolides and strep-
togramin B antibiotics (e.g. MsrE), and such linkers can extend
past the PTC into the nascent peptide exit tunnel38. The length of
the bacterial ABCF ARD generally correlates with the spectrum of
conferred antibiotic resistance. Notable exceptions to this pattern
are OptrA and PoxtA ARE-ABCF which have short interdomain
linkers, yet still confer resistance to some PTC-binding
antibiotics39,40, while typically PTC-protecting ARE-ABCFs
such as VmlR, LsaA and VgaA typically have comparatively long
interdomain linkers46,48.
The available ARE-ABCF-ribosome structures were generated
by in vitro reconstitution. Pseudomonas aeruginosa MsrE, which
confers resistance to tunnel-binding macrolides and strepto-
gramin B antibiotics (that inhibit translation elongation) was
analysed bound to a heterologous Thermus thermophilus initia-
tion complex38. Bacillus subtilis VmlR, which confers resistance
to PLSA antibiotics that bind in the PTC (which stall translation
at initiation), was analysed in complex with a B. subtilis 70S
ribosome arrested during elongation by the presence of a mac-
rolide antibiotic33,45. Structures of native physiological complexes
(such as those generated using pull-down approaches from the
native host) are currently lacking.
In this work, we systematically characterize the antibiotic
resistance specificity and determine the structure of three in vivo
formed ARE-ABCF-70S ribosome complexes using affinity
chromatography and cryo-electron microscopy (cryo-EM). Our
study focusses on ARE-ABCFs that confer resistance to PLSA
antibiotics in clinically relevant Gram-positive pathogens,
namely, the ARE3 representative Enterococcus faecalis LsaA30, as
well as the ARE1 representatives Listeria monocytogenes Lmo0919
(refs. 34–36)—which we have termed VgaL—and the well-
characterized VgaALC protein, initially isolated from Staphylo-
coccus haemolyticus26,36,46,49,50. Staphylococcus and Enterococcus
are commensal organisms that are prevalent in diverse
healthcare-associated infections, and antibiotic resistance is
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spreading through these species51–54. L. monocytogenes is a
foodborne pathogen that poses a particular risk to pregnant
women and immunocompromised patients55. Our structures,
supported by extensive mutagenesis experiments, provide insight
into the mechanism by which these distinct ARE-ABCFs displace
antibiotics from their binding site on the ribosome to confer
antibiotic resistance.
Results
Cryo-EM structures of in vivo formed ARE-ABCF-70S com-
plexes. To obtain in vivo formed ARE-ABCF-70S complexes, we
expressed C-terminally FLAG3-tagged ATPase-deficient EQ2
variants of E. faecalis LsaA, S. aureus VgaALC and L. mono-
cytogenes VgaL in their corresponding native host bacterial spe-
cies. The FLAG3 tag was used for affinity purification of each
protein locked onto their respective ribosomal target. The ARE-
ABCFs co-migrated with the 70S fraction through sucrose gra-
dients—with the complex further stabilized in the presence of
ATP in the case of LsaA and VgaALC—and co-eluted with
ribosomal proteins after affinity purification (Supplementary
Figs. 1–3).
The resulting in vivo formed complexes were characterized by
single-particle cryo-EM (see ‘Methods'), yielding ARE-70S
complexes with average resolutions of 2.9 Å for E. faecalis LsaA,
3.1 Å for S. aureus VgaALC and 2.9 Å for L. monocytogenes VgaL
(Fig. 1a–c, Supplementary Table 4 and Supplementary Figs. 4–6).
In each instance, the globular NBDs of the ARE-ABCF
were bound in the E-site, and the α-helical interdomain linker,
consisting of two α-helices (α1 and α2) and the ARD loop,
extended towards the PTC (Fig. 1a–c). Additionally, a distorted
tRNA occupied the P-site (Fig. 1a–c), similarly to what was
observed previously for P. aeruginosa MsrE and B. subtilis
VmlR38,45. For the LsaA and VgaL samples, occupancy of the
factor on the ribosome was high, with >95% and ~70% of picked
ribosomal particles containing LsaA and VgaL, respectively
(Supplementary Figs. 4 and 6). By contrast, VgaALC had lower
occupancy (~60%), implying that the factor dissociated after
purification and/or during grid preparation (Supplementary
Fig. 5). In silico 3D classification revealed that the major class
not containing VgaALC in the dataset was a 70S ribosome with
P-tRNA, which could also be refined to an average resolution of
3.1 Å (Supplementary Fig. 5). Generally, the 50S ribosomal
subunit and ARE-ABCF interdomain linkers were well-resolved
(Fig. 1d–f and Supplementary Figs. 4–6). While ARE-ABCF
NBDs, occupying the E-site, had a lower resolution—especially in
the regions that contact the ribosomal L1 stalk and the 30S
subunit—the density was nonetheless sufficient to dock and
adjust homology models in each instance (Fig. 1d–f and
Supplementary Figs. 4–6). Densities corresponding to the 30S
subunits were of lower quality, indicating flexibility in this region,
but, with multibody refinement, were nonetheless sufficient to
build near-complete models of each ribosome. Density between
NBD1 and NBD2 of each ARE was most consistent with the
presence of two molecules of ATP (or another NTP) and a cation,
which we tentatively assigned as ATP-1, ATP-2 and magnesium,
respectively. Nonetheless, the density in this region was not
sufficiently detailed to model this region de novo and caution is
warranted in interpreting exact geometries from the model
(Fig. 1d–f and Supplementary Fig. 7). Interestingly, the density
for the nucleobase of ATP-1 bound in the peripheral nucleotide-
binding site of each ARE-ABCF was particularly poor (Supple-
mentary Fig. 7), consistent with the relaxed nucleotide specificity
of these proteins, i.e., the ability of ARE-ABCFs to hydrolyze
other nucleotides, such as CTP, UTP and GTP56.
By comparison to structures of other ABC proteins, the NBDs
adopted a closed conformation bound tightly to each nucleotide
(Supplementary Fig. 8). In each ARE-bound 70S structure, the
ribosomal small subunit was in a semi-rotated state, although this
varied between AREs, with the LsaA- and VgaL-bound ribosomes



































Fig. 1 Cryo-EM structures of ARE-ABCF–ribosome complexes. a–c Cryo-EM maps with isolated densities for a E. faecalis LsaA (green), b S. aureus VgaALC
(magenta), c L. monocytogenes VgaL (yellow) as well as P-site tRNA (cyan), small subunit (SSU, yellow) and large subunit (LSU, grey). d–f Density (grey
mesh) with molecular model for d LsaA, e VgaALC and f VgaL, coloured according to domain as represented in the associated schematics: nucleotide-
binding domain 1 (NBD1, red), antibiotic-resistance domain (ARD, cyan), nucleotide-binding domain 2 (NBD2, blue) and C-terminal extension (CTE, grey,
not modelled). α1 and α2 indicate the two α-helices of the ARD interdomain linker. In d–f, the ATP nucleotides are coloured green.
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In each ARE-ABCF-70S map, the P-site tRNA was distorted
compared to a classic P-site tRNA, resulting in a substantial shift
of the acceptor stem away from the PTC (Supplementary
Fig. 9e–h), as observed previously for MsrE and VmlR38,45. In
each case, the distorted P-site tRNA was rotated compared to a
classic P-site tRNA (21–29°), possibly due to a defined interaction
of the tRNA elbow with the NBD2 of the ARE (Supplementary
Fig. 9i–k). The CCA 3′ end was particularly disordered,
precluding any additional density corresponding to an amino
acid or nascent chain from being modelled, although the
approximate path could be traced in low-pass-filtered maps
(Fig. 1a–c and Supplementary Figs. 4–6). We have used our high-
resolution maps to present a model of the ribosome from the
Gram-positive pathogen L. monocytogenes and update the model
of the S. aureus ribosome57. Our models of the E. faecalis and S.
aureus ribosomes are in good agreement with those recently
described58,59.
LsaA, VgaALC and VgaL bind to translation initiation states. In
each cryo-EM map, the P-site tRNA body was sufficiently well-
resolved to unambiguously assign the density to initiator
tRNAfMet on the basis of (i) general fit between sequence and
density, (ii) the well-resolved codon–anticodon interaction and
(iii) a characteristic stretch of G:C base pairs found in the
anticodon stem loop of tRNAfMet (Fig. 2a–c). Additionally, in the
small subunit mRNA exit tunnel, density corresponding to a
putative Shine-Dalgarno–anti-Shine-Dalgarno helix was
observed, consistent with the ARE-ABCF binding to an initiation
complex containing tRNAfMet (Fig. 2d). LsaA–E. faecalis 70S
samples were further analysed with a custom tRNA microarray,
which confirmed tRNAfMet was the dominant species found in
the sample (Fig. 2e). Collectively, these observations indicate that
in our structures the majority of the ARE-ABCFs are bound to
70S translation initiation complexes. While the initiation state is
also the state that would result from PLSA inhibition, we note that
our complexes were formed in the absence of an antibiotic. Thus,
in our experimental set-up it is likely that the use of the EQ2
mutants traps the ARE-ABCFs on initiation complexes due to the
availability of the E-site.
Further examination of the LsaA-70S volume revealed weak
density in the ribosomal A-site (Supplementary Fig. 4f), suggest-
ing that some complexes had entered the elongation cycle. This
was unexpected, as the distorted P-site tRNA is predicted to
overlap with an accommodated A-site tRNA, although as noted
would be compatible with a pre-accommodated A/T-tRNA45. A
mask around the A-site was used for partial signal subtraction,
and focused 3D classification was used to further sub-sort the
LsaA-70S volume. One class, containing approximately one-third
of the particles, was shown to indeed contain a tRNA in the A-site
(Supplementary Figs. 4 and 10a). This tRNA was poorly resolved,
suggesting flexibility, and was slightly rotated compared to a
canonical, fully accommodated A-site tRNA, and, as for the P-site
tRNA, the acceptor stem was significantly disordered and
displaced (Supplementary Fig. 10b, c). This state likely reflects
an incomplete or late-intermediate accommodation event, as
observed previously when translation is inhibited by PTC-binding
antibiotics hygromycin A or A201A, both of which were shown to
sterically exclude the acceptor stem of a canonical A-site tRNA60.
A very weak density corresponding to an A-site tRNA was also
observed in VgaALC and VgaL volumes, but sub-classification was
unsuccessful for these datasets.
VgaALC and VgaL, both of which belong to the
ARE1 subfamily—although not LsaA, which belongs to the
ARE3 subfamily—contain a short C-terminal extension (CTE)
predicted to form two α-helices20,45. Although not conserved
among all AREs, deletion of the CTE abolished antibiotic
resistance in VmlR and reduced antibiotic resistance in VgaA,
implying that this extension is necessary for function in some
ARE-ABCFs45,49. Density for this region, which emanates from
NBD2 and was located between ribosomal proteins uS7 and uS11,
was present in the VgaALC-70S and VgaL-70S maps and was
essentially consistent with the position of the VmlR CTE,
although was not sufficiently resolved to create a model for this
region. Although bound close to the mRNA exit channel, the
CTEs of VgaALC and VgaL did not contact the Shine-
Dalgarno–anti-Shine-Dalgarno helix of the initiation complexes,
indicating they are not critical for substrate recognition in these




































































































































































































































Fig. 2 The LsaA-70S complex contains an initiator tRNA and SD-helix. a–d Isolated density (grey mesh) with molecular models (sticks) for a initiator
tRNAfMet (cyan), b interaction between AUG start codon of the mRNA (magenta) and anticodon of initiator tRNAfMet (cyan) in the P-site, c three G–C
base pairs specific to the initiator tRNAfMet (cyan) and d helix formed between Shine-Dalgarno (SD) sequence of the mRNA (magenta) and anti-SD of the
16S rRNA (yellow). e Replicate tRNA microarray analysis of the LsaA-70S complex, illustrating the enrichment of initiator tRNAfMet in the LsaA-70S
complex over the lysate. Confidence intervals between replicates were 92%.
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The location and conformation of short and long ARDs on the
ribosome. The ARD loop, positioned between the two long α-
helices that link the NBDs, is a critical determinant of antibiotic
resistance29,38,45,46,56. Despite sharing a similar antibiotic speci-
ficity profile, the ARDs of LsaA, VgaALC, VgaL and VmlR are
divergent in both amino acid composition and length, which is
consistent with the polyphyletic nature of this group but pre-
cludes confident sequence alignment of this region (Fig. 3a).
Despite such sequence divergence, the position of the ARDs on
the ribosome is broadly similar in each instance (Fig. 3b–g). By
comparison to tiamulin, which overlaps with the aminoacyl
moieties of A- and P-tRNAs in the PTC2,60, VmlR, LsaA, VgaALC
and VgaL are all positioned similarly on the ribosome, with the
ARD backbone adjacent to the antibiotic-binding site (Fig. 3b–f).
Compared to VmlR45, the additional residues in the ARDs of
LsaA, VgaALC and VgaL extend away from the antibiotic-binding
site, towards the CCA 3′ end of the distorted P-tRNA (Fig. 3c–f).
By contrast, MsrE, which confers resistance to tunnel-binding
antibiotics deeper in the ribosome, has a longer ARD that extends
both past the PTC to approach the macrolide/streptogramin A-
binding site, as well as towards the distorted P-tRNA (Fig. 3a,
g)38. Thus, the length of the ARD does not necessarily provide
insights into the extent to which the ARD will penetrate into the
ribosomal tunnel and thus one cannot easily predict whether long
ARDs will confer resistance to macrolide antibiotics.
Position of the ARDs with respect to PLSA antibiotic-binding
site. We next made a careful comparison of the LsaA, VgaALC
and VgaL ARDs with the binding sites of relevant antibiotics
within the PTC (Fig. 4a, b)2,5,6,61. For LsaA, the side chain of
Phe257 overlapped with the binding sites of tiamulin, virginia-
mycin M and lincomycin, but was not close to erythromycin
(Fig. 4a–c), consistent with the spectrum of antibiotic resistance
conferred by this protein (Supplementary Table 1). In the VgaALC
ARD, Val219 was situated close to tiamulin and virginiamycin M,
and had a modest predicted overlap with lincomycin (Fig. 4d).
Notably, in the closely related variant VgaA, which has a similar
specificity with modestly higher resistance to tiamulin and vir-
giniamycin M, residue 219 is a glycine, which we predict would
not overlap with the PLSA-binding site46. Thus, VgaALC confers
resistance to virginiamycin M and tiamulin despite the lack of
overlap between the ARE-ABCF and the antibiotic-binding site
(Supplementary Table 2). For VgaL, the closest residue to the
PLSA-binding site was Ala216, which had no predicted overlap
with tiamulin, virginiamycin M or lincomycin (Fig. 4e). VgaL
therefore confers resistance to lincomycin, virginiamycin M and
tiamulin without directly overlapping the binding sites of these
antibiotics. In summary, there was no general pattern of overlap
or non-overlap with the PLSA binding sites among LsaA, VgaALC
and VgaL, and our structural evidence is not consistent with a
steric overlap model of antibiotic egress.
Mutational analysis of LsaA and VgaALC ARDs. Our models of
the ARD loops allowed us to design and test mutants for capacity to
confer antibiotic resistance. Because genetic manipulation in Enter-
ococcus faecalis is difficult, and LsaA complements the B. subtilis
ΔvmlR strain (Supplementary Fig. 11), we performed the mutational
analysis of LsaA in the B. subtilis ΔvmlR background. When LsaA
Phe257, which directly overlaps the PLSA-binding site (Fig. 4c), was
mutated to alanine, no change in resistance was observed (Supple-
mentary Fig. 11). By contrast, mutation of Lys244, which is not
situated close to the PLSA-binding sites but forms a hydrogen bond
with 23S rRNA G2251 and G2252 (Escherichia coli numbering is
used for 23S rRNA nucleotides) of the P-loop (Supplementary
Fig. 11), nearly abolished antibiotic resistance activity (Supplementary
Fig. 12). Taken together, these observations indicate that LsaA does
not confer resistance via simple steric occlusion, and that interactions
with the P-loop may be required for positioning the LsaA ARD.
For VgaALC, extensive alanine mutations within the ARD were
explored (Supplementary Table 2). As expected from the above
analyses and natural variants, mutating Val219—the only residue



































Fig. 3 Comparison of the ARD loops of different ARE-ABCFs. a The sequence length of the ARD loops differs significantly for VmlR, VgaL, VgaALC, LsaA
and MsrE. Although the lack of sequence homology precludes accurate sequence alignment of the ARD loops, the red highlighted residues can be aligned
structurally. Sequences were aligned with Clustal Omega and edited by hand to match the structures. b–g Comparison of the positions of b A-site tRNA
(grey) and P-site tRNA (cyan) from pre-attack state (PDB 1VY4)103, with shifted P-site tRNA (cyan) and ABCF ARD from ribosome complexes containing c
VmlR (orange, PDB 6HA8)45, d LsaA (green), e VgaALC (magenta), f VgaL (yellow) and g MsrE (blue, PDB 5ZLU)38. In b–g, the relative position of either
tiamulin (Tia, magenta, PDB 1XBP)2 or erythromycin (Ery, red, PDB 4V7U)5 has been superimposed. Dashed lines in d–f represent the likely path of the
CCA end of the tRNA.
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affect the antibiotic resistance profile. Three residues at the
beginning of α2, directly after the ARD loop, were required for
resistance: Tyr223, which stacks with U2585 (part of the
pleuromutilin-binding site); Phe224, which stacks with A2602
held in the centre of the ARD; and Lys227, which forms a
hydrogen bond with the 5′ phosphate of C2601 (Supplementary
Table 2). These residues do not overlap with the PLSA-binding
site, but may be required to position the ARD in the PTC to
impede antibiotic binding, or for the folding of the ARD itself
(Supplementary Fig. S12d–f). In the naturally variable VgaALC
ARD loop, mutation of Ser213, which sits adjacent to U2506 and
C2507 (Supplementary Fig. S12e), to alanine similarly reduced
antibiotic resistance (Supplementary Table 2). Of note, mutating
the most conserved residue among VgaA variants in this region,
Lys218, did not substantially affect resistance (Supplementary
Table 2)62. Extensive alanine substitutions in the surrounding
residues that contact the 23S rRNA (Supplementary Fig. 12d–f)
either did not affect, or had only a mild influence on, the
antibiotic resistance conferred by this protein (Supplementary
Table 2). In summary, mutation of VgaALC residues that interact
with 23S rRNA nucleotides that form part of the PLSA-binding
pocket affected antibiotic-resistance activity.
Modulation of the ribosomal antibiotic-binding site by ARE-
ABCFs. We next sought to explore how the ARDs of LsaA,
VgaALC and VgaL affect the conformation of the ribosomal PTC.
The 23S rRNA A2602, which is flexible in the absence of tRNAs
and positioned between the P- and A-tRNAs during peptidyl
transfer, is bound and stabilized by all structurally characterized
ARE-ABCFs. In LsaA and VmlR, a tryptophan stacks and
stabilizes A2602 in a flipped position (Supplementary Fig. 13)45,
reminiscent of the stacking interaction between the equivalent
rRNA nucleotide and Tyr346 of the yeast ABCF protein Arb1
observed in a structure of a ribosome-associated quality control
complex63. In VgaALC, VgaL, and MsrE, A2602 is instead posi-
tioned within the ARD loop, interacting with multiple residues
from the ARE (Supplementary Fig. 13)38.
We have designated four regions within domain V of the 23S
rRNA (Fig. 5a) as PTC loops 1–4 (PL1–4) that comprise the
binding site for the A- and P-site tRNA (Fig. 5b), are close to the
ARD of the ARE-ABCFs (Fig. 5c) and form the binding pocket
for the PLSA antibiotics (Fig. 5d–f). There is a significant overlap
between nucleotides that form the PLSA-binding pockets and
nucleotides that are shifted when LsaA, VgaALC or VgaL are
bound to the ribosome (Fig. 5a). While the ARE-ABCFs come
close to PL1, they do not interact directly and the conformation of
nucleotides within PL1 do not appear to be altered when
comparing the ARE-ABCF and PLSA conformations (Fig. 5g–i
and Supplementary Fig. 14). An exception was a slight rotation of
the A2062 nucleobase (Supplementary Fig. 14), which is most
likely a consequence of drug binding rather than ARE engage-
ment. By contrast, multiple rearrangements were evident in PL2
that appear to arise due to direct contact between the ARD loop
of the ARE-ABCF and the backbone of 23S rRNA nucleotides
A2451–A2452 within PL2 (Fig. 6a–d and Supplementary Fig. 15).
Displacement of the backbone was largest (3.3–4.4 Å) upon LsaA
binding, intermediate (3.1 Å) for VgaALC, and smallest (1.0 Å) for
VgaL, and resulted in corresponding shifts in the position of the
nucleobases that comprise the PLSA-binding pocket (Fig. 6a–d





























Fig. 4 Interaction of LsaA, VgaALC and VgaL at the peptidyl transferase centre. a–b LsaA and distorted P-site tRNA superimposed on a transverse
section of the large subunit (LSU, grey) to reveal a the ARD of LsaA extending into the nascent polypeptide exit tunnel (NPET) and b the relative position of
Phe257 of LsaA to tiamulin (Tia, purple, PDB 1XBP)2 and erythromycin (Ery, red, PDB 4V7U)5. c–k Relative position of LsaA (green, top row, c–e), VgaALC
(pink, middle row, f–h) and VgaL (yellow, bottom row, i–k) to tiamulin (Tia, purple, PDB 1XBP), virginiamycin M (VgM, lime, PDB 4U25)61 and lincomycin
(Lnc, tan, PDB 5HKV)6. When present, clashes in c–k are shown with red outlines.
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Unexpectedly, large changes were also observed in PL3, around
nucleotides U2504–U2506, in the ARE-bound structures, despite the
lack of contact between this region and the ARDs (Fig. 6e–h and
Supplementary Fig. 16). Such shifts are likely a consequence of
disturbances in PL2 since nucleotides within PL2 are in direct contact
with nucleotides in PL3 (Fig. 6i). Specifically, the 23S rRNA
nucleotides G2505 and U2506 in PL2 were shifted by 2.8-3.0 Å when
comparing each ARE-bound 70S to the drug-bound states (Fig. 6e–h
and Supplementary Fig. 17). Additionally, in the LsaA-bound 70S,
U2504 was shifted such that it directly overlaps with the PLSA-
binding site (Fig. 6f). The rearrangement of U2504 appears to arise
because of a cascade of changes in PL2 due to LsaA binding, namely,
A2453 of PL2 is shifted slightly away from the PTC and pairs with
G2499 (instead of U2500), allowing C2452 (which normally pairs
with U2504 and forms part of the PLSA-binding pocket) to instead
hydrogen bond with U2500. The relocation of C2452 frees U2504,
and PL3 more generally, allowing it to reposition into the PLSA-
binding pocket upon LsaA binding (Fig. 6i, j).
U2585, which is part of PL4, forms part of the tiamulin






















































































































































Fig. 5 ARE-ABCF binding induces conformational changes at the PTC. a Secondary structure of peptidyl transferase ring within domain V of the 23S
rRNA, highlighting residues within PTC loops 1–4 (PL1–4) that comprise the binding site of PLSA antibiotics (blue) and/or undergo conformational changes
upon ARE-ABCF binding (grey). b View of the PTC in the pre-peptidyl transfer state (PDB 1VY4)103 with tRNAs and PLs 1–4 from a labelled. c Same view as
b, except with the VgaALC structure shown. For reference, lincomycin is also included (PDB 5HKV)6. Residues coloured yellow had no effect on resistance
when mutated to alanine. For residues coloured blue, antibiotic resistance was significantly affected when mutated to alanine. d–f Binding site of d tiamulin
(Tia, magenta, PDB 1XBP, 3.5 Å)2, e virginiamycin M (VgM, green, PDB 4U25, 2.9 Å)61 and f lincomycin (Lnc, tan, PDB 5HKV, 3.7 Å)6 on the ribosome.
g–i Comparison of conformations of rRNA nucleotides comprising the g Tia, h VgM and i Lnc binding site (shown as grey cartoon ladder representation),
with rRNA conformations when LsaA (green), VgaALC (magenta) or VgaL (yellow) are bound.
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lincomycin (Supplementary Fig. 17). While the density for U2585
is not well-resolved in the LsaA- and VgaL-bound 70S structures,
it appears nevertheless to adopt distinct conformations in the
ARE-ABCFs compared to the drug-bound structures (Supple-
mentary Fig. 17). By contrast, U2585 is clearly ordered in the
VgaALC-70S structure where it stacks upon Tyr223 of VgaALC
(Fig. 6l) in a position that precludes interaction with tiamulin
(Fig. 6k, l) or virginiamycin M (Supplementary Fig. 17).
Substituting Tyr223 of VgaALC to alanine diminished antibiotic
resistance (Supplementary Table 2), indicating that the reposi-
tioning of U2585 is likely to contribute to antibiotic resistance
conferred by this ARE-ABCF.
Discussion
Model of antibiotic resistance mediated by LsaA, VgaALC, and
VgaL. Based on our findings and the available literature on ARE-
ABCFs, we propose a model for how the ARE-ABCFs LsaA,
VgaALC and VgaL confer antibiotic resistance to their respective
host organism (Fig. 7). PLSA antibiotics have binding sites
overlapping with the nascent polypeptide chain, and inhibit
translation at, or soon after, initiation (Fig. 7a)8–10. As observed
in our and previously reported structures38,45, the incoming ARE-
ABCFs bind in the E-site, triggering closure of the L1 stalk and
inducing a distorted conformation of the P-tRNA. The ARD
extends into the antibiotic-binding pocket at the PTC causing
drug release. In LsaA and VgaALC, the changes to the drug-
binding site are substantial, while for VgaL the changes are rather
subtle, as observed in other instances of antibiotic resistance64,65
(Fig. 7b). We observed subpopulations of ARE-ABCF-bound
complexes containing A-tRNA, suggesting that an incoming
ternary complex can still be delivered to the A-site, despite the
distortion of the P-tRNA (Fig. 7c). However, we note that our
complexes were stalled with EQ2-variant AREs, and in a natural
context the ARE may bind and dissociate prior to an A-tRNA
accommodation attempt. We propose that upon dissociation of
the ARE-ABCF from the ribosome, the 3′ end of the A- and P-
tRNAs can re-accommodate at the PTC (Fig. 7d). The trigger for
nucleotide hydrolysis and exit of the ARE-ABCF from the E-site
is unknown. In our model, rapid peptidyl transfer then creates a
short nascent chain that overlaps with the antibiotic-binding site,
thus preventing re-binding of the PLSA drug until the next round
of translation (Fig. 7d). We cannot exclude the possibility that an
A-tRNA may also partially accommodate on the stalled initiation
complex prior to ARE-ABCF binding, and become distorted as
part of a ‘knock-on’ effect of P-tRNA disruption, consistent with
the ability of ARE-ABCFs to ‘reset’ the P-tRNA independently of
additional accommodation events56. In this model, potentially
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Fig. 6 Changes in the PTC induced by ARE-ABCF binding. a–d Effects of ARE binding on PL2 with respect to the tiamulin-binding site (PDB 1XBP)2. a The
tiamulin-binding site only. b–d Same as a but with the LsaA- (b), VgaALC- (c), or VgaL-bound structure (d) superimposed. e–h Same as a–d but focused on
PL3. i, j U2585 in the tiamulin site without (i) or with (j) VgaALC superimposed. Tyrosine223 of VgaALC is indicated. k, l Interaction between PL2 and PL3
contributing to the tiamulin-binding site, either without (k) or with (l) LsaA superimposed.
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necessary to confer resistance. We can also not exclude that the P-
tRNA dissociates following release of the ARE-ABCF and/or that
other factors are involved in recycling of the post-antibiotic
release complexes.
ARE-ABCFs such as LsaA, VgaALC, VgaL and VmlR confer
resistance to PLSA antibiotics but not phenicols or
oxazolidinones25. This observation has been puzzling, as both
groups of antibiotics have overlapping binding sites2–6. However,
phenicols and oxazolidinones inhibit translation during elonga-
tion at specific motifs9,66, while PLSA antibiotics instead inhibit
translation at the initiation stage8–10. This suggests that ARE-
ABCFs such as LsaA, VgaALC, VgaL and VmlR are likely to be
specific for initiation complexes, whereas ARE-ABCFs such as
OptrA and PoxtA may have an additional specificity for drug-
stalled elongation complexes. It will be interesting in the future to
see how OptrA and PoxtA remove phenicols and oxazolidinones
from the ribosome given the short ARD is not predicted to be
able to reach into the PTC.
Another question is whether the EQ2-substituted ATPase-
deficient variants of ARE-ABCF, like the ones used in this study,
bind the ribosome in the pre- or post-antibiotic-release state
(Fig. 7b). Although direct evidence is lacking, three reasons lead
us to propose that these proteins are bound in the post-antibiotic-
release state:
1. In the case of LsaA, VgaALC and VmlR the position of the
ARD directly overlaps with the antibiotic-binding site.
Although the side chain of the overlapping amino acid is
not critical for antibiotic resistance in most instances, the
overlap nonetheless implies mutually exclusive binding.
2. MsrE-EQ2 stimulates dissociation of azithromycin from the
ribosome38.
3. Our attempts to form complexes containing both antibiotic
and ARE-ABCF have been unsuccessful, resulting in
exclusive binding of either the ARE-ABCF or the antibiotic,
similarly to what we observed for TetM, a tetracycline-
resistance ribosome protection protein67.
How does the ARE-ABCF ARD mediate antibiotic resistance
(Fig. 7b, c)? In one model, by analogy to the TetM tetracycline-
resistance protein11,68, the ARD may induce antibiotic dissocia-
tion by a direct steric overlap with the antibiotic. In the case of
VmlR, substitutions of the Phe237 residue that overlaps the
binding site of PLSA antibiotics affect resistance to one of three
relevant antibiotics, indicating that both direct steric overlap and
an indirect mechanism—for example, modulation of the
antibiotic-binding site—can contribute to resistance45. In the
case of MsrE substitution of Leu242, which overlaps with the
erythromycin binding site, as well as adjacent residues abolished
or severely reduced the antibiotic resistance activity of this
protein38. In both cases, a mixture of direct steric overlap and
indirect long-distance effects is consistent with the available
data24. The ARDs of LsaA, VgaALC and VgaL either do not
directly overlap with the PLSA-binding site, or where there is an
overlap, as with LsaA Phe257 and VgaALC Val219, the side chains
are not essential for resistance, implicating an indirect mechanism
for these proteins (Figs. 4–6, Supplementary Figs. 14–16 and
Supplementary Table 2). Alanine mutagenesis instead indicates
that the side chains of residues surrounding the amino acid
closest to the antibiotic-binding pocket, as well as those that
contact the 23S rRNA, are necessary for resistance (Fig. 5c,
Supplementary Figs. 11 and 12 and Supplementary Table 2).
These residues may position the ARD in the PTC. No single set of
23S rRNA rearrangements was identical among LsaA, VgaALC
and VgaL, although displacement of PTC loops PL2 and PL3,
especially residue U2504, was ultimately observed in each ARE-
ABCF-70S structure (Fig. 6). Broadly, changes to the PTC were
similar between the VgaALC- and VgaL-bound 70S structures
(Fig. 5g–i and Supplementary Figs. 14–16), consistent with the
grouping of these proteins together in the ARE1 subfamily20.
While structures of the same or similar antibiotic bound to
ribosomes from different species are generally similar, we cannot
completely exclude that some differences in nucleotide con-
formations arise because of comparing our ARE-ABCF-bound
PTC conformations with antibiotic-ribosome structures from
different species, for example, E. coli for VgM61 and D.
radiodurans for tiamulin2. Similarly, some conformational
variability can also arise due to limitations in resolution of some
of the antibiotic structures, such as the tiamulin-50S structure
that was reported at 3.5 Å2 and the S. aureus lincomycin-50S
structure at 3.7 Å6. A future goal could be to determine higher
resolution structures of the antibiotic-stalled ribosomal com-
plexes prior to ARE-ABCF binding and from the same organisms
as the ARE-ABCF.
In summary, we present three structures of ARE-ABCFs bound
to 70S ribosomes from relevant Gram-positive pathogenic
bacteria and present the model of the ribosome from Listeria
monocytogenes. Our structures and mutagenesis experiments
support an indirect mechanism of ARE-ABCF action, in which a
conformational selection in the PTC, elicited by ARE binding to
the ribosome, leads to antibiotic egress, and hint at a
Fig. 7 Model for ribosome protection by ARE-ABCFs VmlR, LsaA, VgaALC and VgaL. a PLSA-stalled ribosomes containing an initiator tRNA in the P-site
are recognized by the ARE-ABCFs such as VmlR, LsaA, VgaALC and VgaL, which bind to the E-site of the ribosome with a closed ATP-bound conformation.
b Binding of the ARE-ABCF induces a shifted P-site tRNA conformation in the ribosome allowing the ARD of the ARE-ABCF to access the peptidyl
transferase centre (PTC). The ARD induces conformational changes within the 23S rRNA at the PTC that promotes dissociation of the drug from its binding
site (shown as dashed lines). c Aminoacyl-tRNAs can still bind to the ARE-ABCF-bound ribosomal complex, but cannot accommodate at the PTC due to
the presence of the ABCF and shifted P-site tRNA conformation. d Hydrolysis of ATP to ADP leads to dissociation of ARE-ABCF from the ribosome, which
may allow the peptidyl-tRNA as well as the incoming aminoacyl-tRNA to simultaneously accommodate at the PTC. Peptide bond formation can then ensue,
converting the ribosome from an initiation to an elongation (pre-translocation) state, which is resistant to the action of initiation inhibitors, such as PLSA
antibiotics.
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rationalization for the specificity of LsaA, VgaALC and VgaL for
PLSA antibiotics. Each ARE-ABCF binds the 70S similarly as
observed for other bacterial ABCF proteins, but alters the
geometry of the PTC distinctively, consistent with the convergent
evolution—and divergent sequences—of this class of ABCF
proteins.
Methods
Strains and plasmids. All strains and plasmids used in this work are listed in
Table S5. Primers are listed in Table S6.
E. faecalis. OG1RF and TX5332, a LsaA disruption mutant of OG1RF30, were
kindly provided by Dr. Barbara E. Murray (Health Science Center, University of
Texas). All cloning was performed by Protein Expertise Platform at Umeå Uni-
versity. E. faecalis LsaA ORF was PCR amplified from pTEX5333 plasmid and
cloned into pCIE vector69 for cCF10-induced expression. The LsaA ORF was
supplemented with C-terminal His6-TEV-FLAG3-tag (HTF tag) and the ribosome-
binding site was optimized for high expression yield. Point mutations E142Q and
E452Q were introduced to LsaA resulting in pCIE_LsaA-EQ2-HTF.
S. haemolyticus. vga(A)LC gene was PCR-amplified from a S. haemolyticus isolate
held in the O’Neill strain collection at the University of Leeds, using oligonu-
cleotide primers vgaALC-F (5′-GGTGGTGGTACCAGGATGAGGAAATATGA
AAA-3′) and vgaALC-R (5′-GGTGGTGAATTCGGTAATTTATTTATCTAAA
TTTCTT-3′) (engineered restriction sites shown underlined). The protein encoded
by this gene is identical to that previously reported50 (accession number
DQ823382). The fragment was digested with KpnI and EcoRI and ligated into the
tetracycline-inducible expression vector pRMC2 (ref. 70). Constructs encoding the
VgaALC protein fused with a C-terminal FLAG3 tag were obtained by synthesis
(Genewiz), with E105Q, E410Q and EQ2 mutants subsequently created by site-
directed mutagenesis. Generation of other point mutants of untagged Vga(A)LC
was performed by NBS Biologicals, again using chemical synthesis to generate the
original vga(A)LC template, followed by site-directed mutagenesis.
L. monocytogenes. VgaL (Lmo0919). In order to construct L. monocytogenes EGDe::
Δlmo0919, regions corresponding to the upstream and downstream flanking
regions of lmo0919, present on the EGDe genome were amplified with primer pairs
VKT35 (5′-GGGGGGATCCATCACTAGCCGAATCCAAAC-3′), VKT36 (5′-ggg
ggaattcaaaaaataacctcctgaatattttcagag-3′) and VHKT37 (5′-GGGGGAATTCAAAA
AATAACCTCCTGAATATTTTCAGAG-3′), VHKT38 (5′-GGGGCCATGGCG
TGCTGTACGGTATGC-3′), respectively. Fragments were then cloned in tandem
into the pMAD vector using BamHI, EcoRI and NcoRI restriction sites. The
resulting vector, VHp689, was then sequenced to ensure wild-type sequences of
clones. Gene deletion was then performed as per Arnaud et al.71.
lmo0919 was amplified from EGDe genomic DNA using primers VHKT12 (5′-
CCCCCCATGGCATCTACAATCGAAATAAATC-3′) and VHKT39 (5′-
GGGGCTGCAGTTAACTAAATTGCTGTCTTTTTG-3′), and cloned into pIMK3
using NcoI and PstI restriction sites, resulting in plasmid VHp690.
Overlap extension PCR was used in order to introduce a HTF tag at the C-
terminus of lmo0919 (ref. 72). The lmo0919 locus and HTF tag were amplified with
primer pairs VHKT12, VHKT15 (5′-ATGATGATGGCCGCCACTAAATTGCT
GTCTTTTTG-3′) and VHKT14 (5′-AGACAGCAATTTAGTGGCGGCCATC
ATCATCATC-3′), VHKT13 (5′-GGGGCTGCAGTTAGCCTTTGTCATCGTC-3′)
using EGDe genomic DNA and VHp100 template DNA, respectively, producing
fragments with overlapping ends. VHKT12 and VHKT13 were then used to fuse
the fragments and the resulting PCR product was cloned into pIMK3 using NcoI
and PstI sites resulting in VHp692.
To introduce two EQ mutations (E104Q and E408Q) simultaneously into the
VHp692 plasmid, primers VHT266 (5′-TCTTGATCAACCAACCAACTATTTGG
ATATCTACGCAATGGAA-3′) and VHT267 (5′-TTGTTGGTTGGTCTGCTAG
GAGAACACTTGGATTTTGGCGCA-3′) containing both mutations were used to
extend out from lmo0919HTF to amplify the VHp692 backbone. Primers VHT264
(5′-AGCAGACCAACCAACAAGCAATCTTGATGTCG-3′) and VHT265 (5′-TG
GTTGGTTGATCAAGAATCAAGAAATTGGCGT-3′) also containing
lmo0919EQ2 mutations were used to amplify a fragment with overlapping sequence
to the backbone fragment. Both PCR products were then assembled using
NEBuilder® HiFi DNA Assembly Master Mix (NEB), resulting in VHp693.
B. subtilis. To construct the VHB109 [trpC2 ΔvmlR thrC::Phy-spnak-lsaA kmR] strain
untagged LsaA under the control of an IPTG-inducible Phy-spank promotor, a PCR
product encoding lsa(A) was PCR-amplified from pTEX5333 using the primers
VHT127 (5′-CGACGAAGGAGAGAGCGATAATGTCGAAAATTGAACTAA
AACAACTATC-3′) and VHT128 (5′-CACCGAATTAGCTTGCATGCTTATGA
TTTCAAGACAATTTTTTTATCTGTTA-3′). The second PCR fragment encoding
a kanamycin-resistance marker, a polylinker downstream of the Phy-spank pro-
moter and the lac repressor ORF—all inserted in the middle of the thrC gene—was
PCR-amplified from pHT009 plasmid using primers VHT123 (5′-CATTATC
GCTCTCTCCTTCGTCGACTAAGCTAATTG-3′) and VHT125 (5′-TAAGCA
TGCAAGCTAATTCGGTGGAAACGAGG-3′). The two fragments were ligated
using the NEBuilder HiFi DNA Assembly master mix (New England BioLabs,
Ipswich, MA) yielding the pHT009-lsaA plasmid (VHp369) which was used to
transform the VHB5 [trpC2 ΔvmlR] strain. Selection for kanamycin resistance
yielded the desired VHB109 strain. To construct the VHB168 [trpC2 ΔvmlR thrC::
Phy-spnak-lsaAK244A kmR] strain, VHp369 plasmid was subjected to site-directed
mutagenesis using primer VHP303 (5′-GCATCACCTTCACGGTTCATCGACC
ATTCCGCT-3′) and VHP304 (5′-GTACGGCAACGCTAAGGAAAAAGGGA
GCGGGGCGA-3′), according to the directions of Phusion Site-Directed Muta-
genesis Kit (Thermo Fisher Scientific), yielding VHp526 (pHT009-lsaAK244A)
plasmid which was used to transform the VHB5 [trpC2 ΔvmlR] strain. Selection for
kanamycin resistance yielded the desired VHB168 strain. To construct the VHB169
[trpC2 ΔvmlR thrC::Phy-spnak-lsaAF257A kmR] strain, VHp369 plasmid was sub-
jected to site-directed mutagenesis using primer VHP305 (5′-CAATCGCCCCGC
TCCCTTTTTCCTTAGCGT-3′) and VHP306 (5′-CGGATACAGGAGCCATT
GGTGCCCGGGCA-3′), according to the directions of Phusion Site-Directed
Mutagenesis Kit (Thermo Fisher Scientific), yielding, yielding VHp527 (pHT009-
lsaAF257A) plasmid which was used to transform the VHB5 [trpC2 ΔvmlR] strain.
Selection for kanamycin resistance yielded the desired VHB169 strain.
Bacterial transformation
E. faecalis. Electrocompetent cells were prepared as per Bhardwaj et al.73. In short,
an overnight culture grown in the presence of appropriate antibiotics was diluted to
OD600 of 0.05 in 50 mL of BHI media (supplemented with 2 mg/mL kanamycin in
case of TX5332), grown to OD600 of 0.6–0.7 at 37 °C with moderate shaking (160 r.
p.m.). Cells were collected by centrifugation at 3200 × g at 4 °C for 10 min. Cells
were resuspended in 0.5 mL of sterile lysozyme buffer (10 mM Tris-HCl pH 8; 50
mM NaCl, 10 mM EDTA, 35 µg/mL lysozyme), transferred to 1.5 mL Eppendorf
tube and incubated at 37 °C for 30 min. Cells were pelleted at 8700 × g at 4 °C for
10 min and washed three times with 1.5 mL of ice-cold electroporation buffer (0.5
M sucrose, 10% glycerol(w/v)). After last wash the cells were resuspended in 500 µL
of ice-cold electroporation buffer and aliquoted and stored at –80 °C. For elec-
troporation 35 µL of electrocompetent cells were supplemented with 1 µg of plas-
mid DNA, transferred to ice-cold 1 mm electroporation cuvette and electroporated
at 1.8 keV. Immediately after electroporation 1 mL of ice-cold BHI was added to
the cells, the content of the cuvette was transferred to 1.5 mL Eppendorf tubes and
the cells were recovered at 37 °C for 2.5 h and plated onto BHI plates containing
appropriate antibiotics (10 µg/mL chloramphenicol and 2 mg/mL kanamycin).
S. aureus. Preparation and transformation of S. aureus electrocompetent cells
followed the method of Schenk and Laddaga74, though used TSBY (Tryptone soya
broth [Oxoid] containing 2.5% yeast extract) in place of B2 medium. Briefly,
bacteria were grown with vigorous aeration in TSBY to an OD600 of 0.6, harvested
by centrifugation, and washed three times in an equal volume of sterile, deionized
water. Subsequent wash steps used decreasing volumes of 10% glycerol; first 1/5 the
original culture volume, then 1/10, finally resuspending in ~1/32 volume and
storing the resultant electrocompetent cells at −80 °C. For electroporation, 60 µL of
electrocompetent cells were mixed with ≧1 µg of plasmid DNA in a 1 mm elec-
troporation cuvette at room temperature and pulsed at 2.3 kV, 100Ω, 25 μFD.
Immediately after electroporation, 390 µL room temperature TSBY was added to
the cells and incubated with aeration at 37 °C for 1–2 h, before plating onto
tryptone soya agar with appropriate antibiotic selection. Using this method,
sequence-verified constructs established in E. coli were first transferred into the
restriction deficient S. aureus RN4220 strain75, before recovery and introduction
into S. aureus SH1000 (refs. 76,77).
L. monocytogenes. L. monocytogenes EGD-e was transformed with pIMK3 inte-
grative plasmids via conjugation. E. coli S17.1 harbouring pIMK3 and its deriva-
tives was grown at 37 °C overnight in LB media supplemented with 50 µg/mL
kanamycin; 1 mL of culture was washed three times with sterile BHI media to
remove antibiotics. Two hundred microliters of washed E. coli culture was mixed
with an equal volume of L. monocytogenes overnight culture grown at 37 °C in BHI
media. Two hundred microliters of mixed bacterial suspension was then dropped
onto a conjugation filter (Millipore #HAEP047S0) placed onto a BHI agar plate
containing 0.2 µg/mL penicillin-G. After overnight incubation at 37 °C, bacterial
growth from the filter was resuspended in 1 mL of BHI and 100–300 µL plated onto
BHI agar plates supplemented with 50 µg/mL kanamycin (to select for pIMK3), 50
µg/mL nalidixic acid and 10 µg/mL colistin sulfate (Sigma-Aldrich C4461-100MG).
Resulting colonies were checked for correct integration via PCR and subsequent
sequencing using primers VHKT42 and VHKT43.
Antibiotic susceptibility testing. Minimum inhibitory concentrations (MIC)
were determined based on guidelines from the European Committee on Anti-
microbial Susceptibility Testing (EUCAST) (http://www.eucast.org/
ast_of_bacteria/mic_determination).
E. faecalis. Bacteria were grown in BHI media supplemented with 2 mg/mL
kanamycin (to prevent lsa revertants), 0.1 mg/mL spectinomycin (to maintain the
pCIEspec plasmid), 100 ng/mL of cCF10 peptide (to induce expression of LsaA
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protein) as well as increasing concentrations of antibiotics was inoculated with 5 ×
105 CFU/mL (OD600 of approximately 0.0005) of E. faecalis ΔlsaA (lsa::Kan) strain
TX5332 transformed either with empty pCIEspec plasmid or with pCIEspec
encoding LsaA. After 16–20 h at 37 °C without shaking, the presence or absence of
bacterial growth was scored by eye.
S. aureus. Bacteria were grown in cation-adjusted Mueller-Hinton Broth (MHB) at
37 °C with vigorous aeration, supplemented with 10 mg/L chloramphenicol to
maintain the pRMC2 plasmid. Upon reaching an absorbance of OD625 of 0.6,
anhydrotetracycline (ATC) (Sigma-Aldrich, UK) was added at a final concentra-
tion of 100 ng/mL to induce expression from pRMC2, and incubated for a further
3 h. Cultures were then diluted to 5 × 105 CFU/mL using MHB supplemented with
ATC (100 ng/mL) and used in MIC determinations essentially as described above
(though cultures were shaken).
L. monocytogenes. Bacteria were grown in BHI media supplemented with 50 µg/mL
kanamycin (to prevent loss of the integrated pIMK3 plasmid), 1 mM of IPTG (to
induce expression of VgaL protein) as well as increasing concentrations of anti-
biotics was inoculated with 5 × 105 CFU/mL (OD600 of approximately 0.0003) of L.
monocytogenes EGD-e wild-type strain or EGD-e::Δlmo0919 strain transformed
either with empty pIMK3 plasmid or with pIMK3 encoding VgaL variants. After
16–20 h at 37 °C without shaking, the presence or absence of bacterial growth was
scored by eye.
B. subtilis (for LsaA mutants). B. subtilis strains were pre-grown on LB plates
supplemented with 1 mM IPTG overnight at 30 °C. Fresh individual colonies were
used to inoculate filtered LB medium in the presence of 1 mM IPTG, and OD600
adjusted to 0.01. The cultures were seeded on a 100-well honeycomb plate (Oy
Growth Curves AB Ltd, Helsinki, Finland), and plates incubated in a Bioscreen C
(Labsystems, Helsinki, Finland) at 37 °C with continuous medium shaking. After
90 min (OD600 ≈ 0.1), antibiotics were added and growth was followed for an
additional 6 h.
Preparation of bacterial lysates
Preparation of bacterial biomass. E. faecalis: E. faecalis TX5332 transformed with
pCIE plasmids (either empty vector and expressing either wild type or EQ2 variants
of C-terminally HTF-tagged LsaA) were grown overnight from single colony in
BHI supplemented with 2 mg/mL kanamycin and 10 µg/mL of chloramphenicol.
Next day overnight cultures were diluted to starting OD600 of 0.05 in 160 mL BHI
supplemented with 0.5 mg/mL kanamycin and 10 µg/mL of chloramphenicol. Cells
were grown with intensive shaking at 37 °C till OD600 of 0.6 and were induced with
300 ng/mL of cCF10 peptide for 30 min prior harvesting by centrifugation at
10,000 × g for 15 min at 4 °C.
S. aureus: S. aureus SH1000 transformed with pRMC2 plasmids (empty vector,
wild type and EQ2 VgaALC-FLAG3) were grown in LB supplemented with 25 µg/
mL of chloramphenicol. Saturated cultures were diluted to an OD600 of 0.1 in 400
mL LB supplemented with 20 µg/mL of chloramphenicol and grown at 37 °C with
vigorous aeration to an OD600 of 0.6. Protein expression was induced with 100 ng/
mL of anhydrotetracycline for 30 min prior to harvesting by centrifugation at 10
000 × g for 15 min at 4 °C.
L. monocytogenes: L. monocytogenes EGD-e was transformed with pIMK3
plasmids (empty vector, wild type and EQ2 VgaL-HTF) were grown overnight from
single colony in LB supplemented with 50 µg/mL of kanamycin. Next day
overnight cultures were diluted till starting OD600 of 0.005 in 200 mL BHI
supplemented with 50 µg/mL of kanamycin. Cells were grown at 37 °C with
shaking at 160 r.p.m. till OD600 of 0.6 and were induced with 1 mM IPTG for 60
min prior harvesting by centrifugation at 10,000 × g for 15 min at 4 °C.
Preparation of clarified lysates. Cell pellets were resuspended in 1.5 mL of cell lysis
buffer (95 mM KCl, 5 mM NH4Cl, 20 mM HEPES pH 7.5, 1 mM DTT, 5 mM Mg
(OAc)2, 0.5 mM CaCl2, 8 mM putrescine, 1 mM spermidine, 1 tablet of cOmplete™
EDTA-free Protease Inhibitor Cocktail (Roche) per 10 mL of buffer and in the
absence or presence of either 0.5 or 0.75 mM ATP), resuspended cells were opened
by a FastPrep homogeniser (MP Biomedicals) with 0.1 mm zirconium beads
(Techtum) in four cycles by 20 s with 1 min chill on ice. Cell debris was removed
after centrifugation at 14,800 × g for 15 min at 4 °C. Total protein concentration in
supernatant was measured by Bradford assay (Bio-Rad), supernatant was aliquoted
and frozen in liquid nitrogen.
Polysome fractionation and immunoblotting
Sucrose density gradient centrifugation. After melting the frozen lysates on ice, 2
A260 units of each extract was aliquoted into three tubes and supplemented with or
without 0.5–0.75 mM ATP and was loaded onto 5–25 or 7–35% (w/v) sucrose
density gradients in HEPES:Polymix buffer78, 5 mM Mg(OAc)2 and supplemented
or not with 0.5–0.75 mM ATP. Gradients were resolved at 245,000 × g for 2.5 h at
4 °C in an SW41 rotor (Beckman) and analysed and fractionated using Biocomp
Gradient Station (BioComp Instruments) with A280 as a readout.
Immunoblotting. LsaA and VgaALC: Schleicher & Schuell Minifold II Slot Blot
System SRC072/0 44-27570 manifold was used for transferring samples from
sucrose gradient fractions to PVDF membranes (Immobilon PSQ, Merck Milli-
pore). Shortly, 15–100 μL of each sucrose gradient fraction was added to 200 μL of
slot-blotting buffer (20 mM HEPES:KOH pH 7.5, 95 mM KCl, 5 mM NH4Cl, 5 mM
Mg(OAc)2) in slots and blotted onto PVDF membrane that had been activated with
methanol for 1 min, wetted in MilliQ water and equilibrated with Slot-blotting
Buffer (1c PM 5mM Mg2+ without putrescine and spermidine) for 10 min. After
blotting of the samples each slot was washed twice with 200 μL of Slot-blotting
Buffer. The membrane was removed from the blotter, transferred to hybridization
bottle, equilibrated for 10 min in PBS-T (1× PBS supplemented with 0.05% Tween-
20) and blocked in PBS-T supplemented with 5% w/v nonfat dry milk for 1 h.
Antibody incubations were performed for 1 h in 1% nonfat dry milk in PBS-T with
five 5-min washes in fresh PBS-T between and after antibody incubations. HTF-
tagged LsaA and FLAG3-tagged VgaALC proteins were detected using anti-Flag M2
primary (Sigma-Aldrich, F1804; 1:10,000 dilution) antibodies combined with anti-
mouse-HRP secondary (Rockland; 610-103-040; 1:10,000 dilution) antibodies. An
ECL detection was performed on ImageQuant LAS 4000 (GE Healthcare) imaging
system using Pierce® ECL western blotting substrate (Thermo Scientific). The
blotting and all incubations were performed at room temperature in a
hybridization oven.
VgaL (Lmo0919): Western blotting of lysates on sucrose gradient fractionation
was performed as previously described78. In all, 1.5 mL of 99.5% ethanol was added
to each 0.5 mL sucrose fraction and precipitated at −20 °C overnight. Samples were
then pelleted via centrifugation for 30 min at 14,800 × g, air dried and resuspended
in 2× SDS loading buffer (100 mM Tris-HCl pH 6.8, 4% SDS w/v, 0.02%
bromophenol blue, 20% glycerol (w/v), 4% β-mercaptoethanol). Samples were
resolved on a 12% SDS-PAGE gel and transferred to a nitrocellulose membrane
(pore size 0.2 μM, BioTraceTM NT) using the Bio-Rad Trans-Blot Turbo Transfer
apparatus (30 min, 1 A, 25 V). The membrane was then blocked for 1 h at room
temperature in PBS-T (1× PBS, 0.05% Tween-20) with 5% (w/v) nonfat dry milk.
VgaL-HTF was then detected using anti-Flag M2 primary antibodies as described
above for Lsa and VgaALC. VgaL-HTF was detected using anti-Flag M2 primary
(Sigma-Aldrich, F1804; 1:10,000 dilution) antibodies combined with anti-mouse-
HRP secondary (Rockland; 610-103-040; 1:10,000 dilution) antibodies.
Affinity purification on anti-FLAG M2 affinity gel. One hundred microlitres of
well mixed anti-FLAG M2 Affinity Gel aliquots were loaded on columns (Micro
Bio-Spin Columns, Bio-Rad) and washed two times with 1 mL of cell lysis buffer by
gravity flow. All incubations, washings and elutions were done at 4 °C.
The total protein concentration of each lysate was adjusted to 2 mg/mL with cell
lysis buffer and 1 mL of each lysate was loaded on columns and incubated for 2 h
with end-over-end mixing for binding. The columns were washed five times by 1
mL of cell lysis buffer by gravity flow. For elution of FLAG-tagged proteins and
their complexes 100–300 µL of 0.1 mg/mL FLAG3 peptide (Sigma) was added to
samples, the solutions were incubated at 4 °C for 20 min with end-over-end mixing.
Elutions were collected by centrifugation at 2000 × g for 2 min at 4 °C.
Twenty microlitre-aliquots of collected samples (flow-through, washes and
elutions) were mixed with 5 µL of 5× SDS loading buffer and heated up at 95 °C for
15 min. The beads remaining in the column were washed twice with 1 mL of cell
lysis buffer and resuspended in 100 µL of 1× SDS loading buffer. Denatured
samples were resolved on 12–15% SDS-PAGE. SDS-gels were stained by Blue-
Silver Coomassie Staining79 and washed with water for 6 h or overnight before
imaging with LAS 4000 (GE Healthcare).
tRNA microarrays. To fully deacylate tRNAs, eluates and input lysate samples
from two biological replicates were mixed with 80 µL 250 mM Tris-HCl, pH 9.0,
10 µL 0.2 M EDTA, 10 µL 1% SDS, and incubated for 45 min, and neutralized with
200 µL 1M NaOAc, pH 5.5, before mixing 1:1 with acidic phenol:chloroform
alcohol 5:1. The supernatant was precipitated with ethanol and dissolved in
ddH2O.
tRNA microarrays were performed as described80. Briefly, using the unique
invariant single-stranded 3′-NCCA-ends of intact tRNA a Cy3-labelled or Atto647-
labelled RNA/DNA hybrid oligonucleotide was ligated to the tRNA extracted from
the ARE-immunoprecipitated samples and total E. faecalis tRNA (from the lysate),
respectively. Labelled tRNA was purified by phenol:chloroform extraction and
loaded on a microarray containing 24 replicates of full-length tDNA probes
recognizing E. faecalis tRNA isoacceptors. Fluorescence signals were normalized to
four in vitro-transcribed human tRNAs, spiked into each sample. Microarrays were
statistically analysed with in-house scripts written in Python 3.7.0. Data are
available at the Gene Expression Omnibus under accession GSE 162168.
Grid preparation, cryo-electron microscopy and single-particle reconstruction
Preparation of cryo-EM grids and data collection. Elutions from LsaA and VgaL
pull-downs were loaded on grids within 2 h after obtaining them without freezing,
samples were kept on ice. The VgaALC sample was frozen in liquid nitrogen after
pull-down, defrosted and loaded later. After glow-discharging of grids, 3.5 μL of
sample was loaded on grids in Vitrobot (FEI) in conditions of 100% humidity at
4 °C, blotted for 5 s and vitrified by plunge-freezing in liquid ethane. Samples were
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imaged on a Titan Krios (FEI) operated at 300 kV at a nominal magnification of
×130k (LsaA) or ×165k (VgaALC and VgaL, 1.09 Å/pixel and 0.86 Å/pixel,
respectively, later estimated to be 1.041 and 0.82 Å/pixel, respectively, by com-
paring refined maps to structures with known magnification) with a Gatan K2
Summit camera at an exposure rate of 5.80 electrons/pixel/s with a 4 s exposure
and 40 frames (LsaA), or 20 frames (VgaALC and VgaL) using the EPU software.
Quantifoil 1.2/1.3 Cu200 grids were used for LsaA and VgaALC and Quantifoil 2/2
Cu200 grids were used for VgaL.
Single-particle reconstruction. Motion correction was performed with MotionCor2
with 5 × 5 patches81. Relion 3.0 or 3.1 was used for further processing unless
otherwise stated and resolutions are reported according to the so-called ‘gold
standard’ criteria82–84. CTFFIND4 (LsaA dataset) or Gctf v1.06 (VgaALC and VgaL
datasets) was used for CTF estimation85,86. Particles were picked with Gautomatch
(https://www2.mrc-lmb.cam.ac.uk/research/locally-developed-software/zhang-
software/#gauto, developed by K. Zhang) without supplying a reference, and in the
case of LsaA, re-picked using RELION autopicker after templates were generated
by 2D classification. Particles were initially extracted at three times the original
pixel size and subjected to 2D classification. Classes that resembled ribosomes were
used for 3D refinement, with a 60 Å low-pass filter applied to initial references. For
3D refinement of LsaA-70S, the initial reference was EMDB-0176, a B. subtilis 70S
ribosome with no factor bound in the E-site45; for VgaALC-70S and VgaL-70S 3D
refinements the RELION initial model job type was used to create a reference from
particles selected after 2D classification. 3D classification was performed without
angular sampling, and classes of interest were re-extracted at 1.041 Å/pixel (LsaA)
or 0.82 Å/pixel (VgaALC and VgaL) for further refinement.
In the case of LsaA, after initial 3D classification, a soft mask around the A-site
was used for partial signal subtraction followed by focussed classification. The
classes with the strongest and weakest A-site density were selected for signal
restoration and refinement. In the case of the VgaALC dataset, initial 3D
classification yielded a class with apparent sub-stoichiometric density in the E-site
corresponding to VgaALC. Micrographs with poor values from CTF estimation
were discarded, particles were re-extracted, subjected to an additional 2D
classification and 3D refinement, followed by Bayesian polishing and CTF
refinement. An additional 3D classification yielded a class with strong E-site
density corresponding to the factor. Refer to Supplementary Figs. 4–6 for details.
For multibody refinements, soft masks around the small subunit body, small
subunit head, and large subunit/ARD were applied. In the case of the VgaALC
dataset, particles were first re-extracted in a smaller box (360 × 360 pixels) and
subjected to 3D refinement prior to multibody refinement.
ResMap was used to estimate local resolution87. Maps were locally filtered using
SPHIRE88.
Molecular modelling. For the E. faecalis and L. monocytogenes ribosomes, homology
models were generated with SWISS-MODEL89, mostly from PDB 6HA1/6HA8
(ref. 45). PDBs 4YBB90 5MDV91 were used as additional templates and references
where necessary, 4V9O92 was used for bS21, 7K00 (ref. 93) for bL31, 5ML7 (ref. 94)
and 3U4M95 were used for the L1 stalk region, 5AFI96 and 5UYQ97 were used for
tRNAs, and 6QNQ was used to help tentatively place metal ions98. PDB 5LI0
(ref. 57) was used as a starting model for the S. aureus ribosome. Where appro-
priate, individual components of multibody refinements were fitted into density
from the corresponding locally filtered map to help modelling. Models were
adjusted with Coot99 and refined using locally filtered maps in Phenix version dev-
2947-000 (ref. 100).
Figures were created with PyMOL 2.0 (Schrödinger, LLC), UCSF Chimera101,
UCSF ChimeraX102, RELION82, and Igor Pro (WaveMetrics, Inc.). Structures were
aligned in PyMOL using the 23S rRNA unless otherwise noted. Subunit rotation
was visualized in PyMOL using the modevectors script, which was initially
developed by Sean Law and modified by others, and the rotation angle measured
using the draw_axis script, made by Pablo Guardado Calvo.
Figures were assembled with Adobe Illustrator (Adobe Inc.).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Micrographs have been deposited as uncorrected frames in the Electron Microscopy
Public Image Archive (EMPIAR) with the accession codes EMPIAR-10682 (LsaA
immunoprecipitation), EMPIAR-10683 (VgaALC immunoprecipitation), and EMPIAR-
10684 (VgaL immunoprecipitation). Cryo-EM maps have been deposited in the Electron
Microscopy Data Bank (EMDB) with accession codes EMD-12331 (LsaA-70S), EMD-
12332 (VgaALC-70S), EMD-12333 (S. aureus 70S with P-tRNA from VgaALC
immunoprecipitation) and EMD-12334 (VgaL-70S). Molecular models have been
deposited in the Protein Data Bank with accession codes 7NHK (LsaA-70S), 7NHL
(VgaALC-70S), 7NHM (S. aureus 70S with P-tRNA from VgaALC immunoprecipitation)
and 7NHN (VgaL-70S). Microarray data have been deposited in Gene Expression
Omnibus under accession GSE 162168. Scripts for analysing microarray data are
available upon request to C.P. and Z.I. Source data are provided with this paper.
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